Log in to save to my catalogue

Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic l...

Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic l...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2838323877

Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study

About this item

Full title

Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study

Publisher

United States: Public Library of Science

Journal title

PLoS medicine, 2023-06, Vol.20 (6), p.e1004157

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Patients with chronic lymphocytic leukemia (CLL) have reduced seroconversion rates and lower binding antibody (Ab) and neutralizing antibody (NAb) titers than healthy individuals following Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA vaccination. Here, we dissected vaccine-mediated humoral and cellular responses to understand t...

Alternative Titles

Full title

Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2838323877

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2838323877

Other Identifiers

ISSN

1549-1676,1549-1277

E-ISSN

1549-1676

DOI

10.1371/journal.pmed.1004157

How to access this item